Efficacy and safety of CYP2C19 genotype in stroke or transient ischemic attack patients treated with clopidogrel monotherapy or clopidogrel plus aspirin: Protocol for a systemic review and meta-analysis

BACKGROUND: The relationship of CYP2C19 genotype and clinical efficacy in stroke or transient ischemic attack (TIA) patients treated with clopidogrel monotherapy or clopidogrel plus aspirin remains unknown. We thus aim to conduct a meta-analysis to appraise evidence on the association of CYP2C19 gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Jia-Chen, Cui, Min, Pan, Mang-Mang, Gu, Zhi-Chun, Li, Wen-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023652/
https://www.ncbi.nlm.nih.gov/pubmed/29901608
http://dx.doi.org/10.1097/MD.0000000000011060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023652/
https://www.ncbi.nlm.nih.gov/pubmed/29901608
http://dx.doi.org/10.1097/MD.0000000000011060

Ejemplares similares